Pacific Biosciences of California, Inc. (NASDAQ:PACB)

CAPS Rating: 3 out of 5

Recs

3
Player Avatar NeuroNerd (< 20) Submitted: 9/30/2011 1:24:34 PM : Outperform Start Price: $3.41 PACB Score: +6.72

The floor where I work just received one of their next-gen sequencers. It is quite possibly the coolest thing I have ever seen. I think it is fair to say that adoption will be slower than management's original optimistic projections because of the price tag; however, my suspicion is that the razor-and-blade model will allow them to eventually become profitable as specialized centers like ours adopt them. They really do have capabilities that leave the competition in the dust for certain applications.

Featured Broker Partners


Advertisement